Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;101(1):32-41.
doi: 10.1111/cen.15065. Epub 2024 May 1.

A long-term prognosis study of human USP8-mutated ACTH-secreting pituitary neuroendocrine tumours

Affiliations

A long-term prognosis study of human USP8-mutated ACTH-secreting pituitary neuroendocrine tumours

Hui Miao et al. Clin Endocrinol (Oxf). 2024 Jul.

Abstract

Objective: Somatic variants in the ubiquitin-specific protease 8 (USP8) gene are the most common genetic cause of Cushing disease. We aimed to explore the relationship between clinical outcomes and USP8 status in a single centre.

Design, patients and measurements: We investigated the USP8 status in 48 patients with pituitary corticotroph tumours. A median of 62 months of follow-up was conducted after surgery from November 2013 to January 2015. The clinical, biochemical and imaging features were collected and analysed.

Results: Seven USP8 variants (p.Ser718Pro, p.Ser719del, p.Pro720Arg, p.Pro720Gln, p.Ser718del, p.Ser718Phe, p.Lys713Arg) were identified in 24 patients (50%). USP8 variants showed a female predominance (100% vs. 75% in wild type [WT], p = .022). Patients with p.Ser719del showed an older age at surgery compared to patients with the p.Pro720Arg variant (47- vs. 24-year-olds, p = .033). Patients with p.Pro720Arg showed a higher rate of macroadenoma compared to patients harbouring the p.Ser718Pro variant (60% vs. 0%, p = .037). No significant differences were observed in serum and urinary cortisol and adrenocorticotropin hormone (ACTH) levels. Immediate surgical remission (79% vs. 75%) and long-term hormone remission (79% vs. 67%) were not significantly different between the two groups. The recurrence rate was 21% (4/19) in patients harbouring USP8 variants and 13% (2/16) in WT patients. Recurrence-free survival presented a tendency to be shorter in USP8-mutated individuals (76.7 vs. 109.2 months, p = .068).

Conclusions: Somatic USP8 variants accounted for 50% of the genetic causes in this cohort with a significant female frequency. A long-term follow-up revealed a tendency toward shorter recurrence-free survival in USP8-mutant patients.

Keywords: ACTH; Cushing's disease; USP8; recurrence; remission.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Hofmann BM, Hlavac M, Martinez R, Buchfelder M, Müller OA, Fahlbusch R. Long‐term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J Neurosurg. 2008;108(1):9‐18. doi:10.3171/jns/2008/108/01/0009
    1. Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing's syndrome. Lancet. 2015;386(9996):913‐927. doi:10.1016/s0140-6736(14)61375-1
    1. Sundaram NK, Carluccio A, Geer EB. Characterization of persistent and recurrent Cushing's disease. Pituitary. 2014;17(4):381‐391. doi:10.1007/s11102-013-0511-3
    1. Chen J, Jian X, Deng S, et al. Identification of recurrent USP48 and BRAF mutations in Cushing's disease. Nat Commun. 2018;9(1):3171. doi:10.1038/s41467-018-05275-5
    1. Ma ZY, Song ZJ, Chen JH, et al. Recurrent gain‐of‐function USP8 mutations in Cushing's disease. Cell Res. 2015;25(3):306‐317. doi:10.1038/cr.2015.20

Substances

LinkOut - more resources